PULMONX CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
PULMONX CORPORATION (LUNG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 2.36 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2026-08-04
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2026-06-30 was -27.26K shares, a 118.73% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2026-03-31 was 2.38M shares, a 2.98% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2025-12-31 was 63.80K shares, a 246.51% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2025-09-30 was 140.89K shares, a 1.05% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2025 was 2.67M shares, a 26.07% increase from fiscal 2024.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2024 was 2.11M shares, a 20.73% increase from fiscal 2023.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2023 was 1.75M shares, a 58.16% increase from fiscal 2022.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, vested, number of shares for fiscal 2022 was 1.11M shares, a 47.33% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 12 month |
|---|---|---|---|---|
| 2026-06-30 | -27.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 2.36M shares 10-Q · filed 2026-08-04 | 2.42M shares derived: sum of 3 quarters · filed 2026-08-04 | 2.56M shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 2.38M shares 10-Q · filed 2026-05-04 | 2.45M shares derived: sum of 2 quarters · filed 2026-05-04 | 2.59M shares derived: sum of 3 quarters · filed 2026-05-04 | 2.74M shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 63.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 204.69K shares derived: sum of 2 quarters · filed 2026-03-10 | 350.26K shares derived: sum of 3 quarters · filed 2026-03-10 | 2.67M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 140.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 286.46K shares derived: sum of 2 quarters · filed 2025-11-12 | 2.60M shares 10-Q · filed 2025-11-12 | 2.62M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 145.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | 2.46M shares 10-Q · filed 2025-08-01 | 2.48M shares derived: sum of 3 quarters · filed 2025-08-01 | 2.62M shares derived: sum of 4 quarters · filed 2025-08-01 |
| 2025-03-31 | 2.32M shares 10-Q · filed 2025-05-02 | 2.33M shares derived: sum of 2 quarters · filed 2025-05-02 | 2.48M shares derived: sum of 3 quarters · filed 2025-05-02 | 2.53M shares derived: sum of 4 quarters · filed 2025-05-02 |
| 2024-12-31 | 18.41K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 160.80K shares derived: sum of 2 quarters · filed 2025-02-25 | 216.06K shares derived: sum of 3 quarters · filed 2025-02-25 | 2.11M shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 142.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 197.64K shares derived: sum of 2 quarters · filed 2024-11-01 | 2.10M shares 10-Q · filed 2024-11-01 | 2.27M shares derived: sum of 4 quarters · filed 2024-11-01 |
| 2024-06-30 | 55.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 1.95M shares 10-Q · filed 2024-08-02 | 2.13M shares derived: sum of 3 quarters · filed 2024-08-02 | 2.32M shares derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | 1.90M shares 10-Q · filed 2024-05-03 | 2.08M shares derived: sum of 2 quarters · filed 2024-05-03 | 2.26M shares derived: sum of 3 quarters · filed 2024-05-03 | 2.40M shares derived: sum of 4 quarters · filed 2024-05-03 |
| 2023-12-31 | 176.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 362.56K shares derived: sum of 2 quarters · filed 2024-02-27 | 503.57K shares derived: sum of 3 quarters · filed 2024-02-27 | 1.75M shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 185.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 326.65K shares derived: sum of 2 quarters · filed 2023-11-03 | 1.57M shares 10-Q · filed 2023-11-03 | 1.63M shares derived: sum of 4 quarters · filed 2023-11-03 |
| 2023-06-30 | 141.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 1.39M shares 10-Q · filed 2023-08-04 | 1.45M shares derived: sum of 3 quarters · filed 2023-08-04 | 1.59M shares derived: sum of 4 quarters · filed 2023-08-04 |
| 2023-03-31 | 1.25M shares 10-Q · filed 2023-05-08 | 1.31M shares derived: sum of 2 quarters · filed 2023-05-08 | 1.45M shares derived: sum of 3 quarters · filed 2023-05-08 | 1.57M shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 59.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 203.08K shares derived: sum of 2 quarters · filed 2023-03-01 | 317.02K shares derived: sum of 3 quarters · filed 2023-03-01 | 1.11M shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 143.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 257.66K shares derived: sum of 2 quarters · filed 2022-11-08 | 1.05M shares 10-Q · filed 2022-11-08 | 1.11M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 113.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 904.46K shares 10-Q · filed 2022-08-08 | 962.26K shares derived: sum of 3 quarters · filed 2022-08-08 | 955.80K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 790.52K shares 10-Q · filed 2022-05-09 | 848.32K shares derived: sum of 2 quarters · filed 2022-05-09 | 841.85K shares derived: sum of 3 quarters · filed 2022-05-09 | 318.86K shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 57.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 51.34K shares derived: sum of 2 quarters · filed 2022-03-01 | -471.66K shares derived: sum of 3 quarters · filed 2022-03-01 | 751.75K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | -6.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -529.46K shares derived: sum of 2 quarters · filed 2021-11-09 | 693.95K shares 10-Q · filed 2021-11-09 | 775.72K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | -523.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 700.42K shares 10-Q · filed 2021-08-10 | 782.19K shares derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | 1.22M shares 10-Q · filed 2021-05-12 | 1.31M shares derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2020-12-31 | 81.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 1.22M shares 10-K · filed 2021-03-15 | ||
| 2020-09-30 | 1.14M shares 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |